Phathom Pharmaceuticals (PHAT) Profit Margin
Market Cap: $286.21M
Avg Volume: 1.21M
Industry: Biotechnology
Sector: Healthcare
Profit Margin Summary (Annual)
According to Phathom Pharmaceuticals's latest annual financial reports, the company has an operating profit margin of -502.18%. This metric indicates the percentage of revenue that remains after deducting operating expenses, excluding interest and taxes.
The company's gross profit margin stands at 85.57%, reflecting the percentage of revenue that exceeds the cost of goods sold (COGS).
The pretax profit margin is -605.09%, indicating the percentage of revenue that remains after deducting all expenses except taxes.
Lastly, the net profit margin is -605.09%, which shows the percentage of revenue that remains as profit after all expenses, including taxes, have been deducted.
The trailing twelve months (TTM) operating profit margin is -502.18%, providing a more up-to-date view of the company's financial health.
Operating Margin
-502.18%
Gross Margin
85.57%
Pretax Margin
-605.09%
Net Margin
-605.09%
Historical Operating Profit Margin
Historical Gross Profit Margin
Historical Pretax Profit Margin
Historical Net Profit Margin
Phathom Pharmaceuticals Historical Profit Margins
Phathom Pharmaceuticals Profit Margin History
The table below shows the margins for each year, with the latest data available for the last fiscal year 2024.
| Year | Operating Margin | Gross Margin | Pretax Margin | Net Margin |
|---|---|---|---|---|
| 2024 | -502.18% | 85.57% | -605.09% | -605.09% |
| 2023 | -24532.55% | 75.51% | -29558.94% | -29558.94% |
| 2022 | 0.00% | 0.00% | 0.00% | 0.00% |
| 2021 | 0.00% | 0.00% | 0.00% | 0.00% |
| 2020 | 0.00% | 0.00% | 0.00% | 0.00% |
| 2019 | 0.00% | 0.00% | 0.00% | 0.00% |
| 2018 | 0.00% | 0.00% | 0.00% | 0.00% |
Related Metrics
Explore detailed financial metrics and analysis for PHAT.